The critical role of metabolic pathways in aging

Nir Barzilai, Derek M. Huffman, Radhika H. Muzumdar, Andrzej Bartke

Research output: Contribution to journalArticle

294 Citations (Scopus)

Abstract

Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death. The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids. Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents. Meanwhile, pharmacologic interventions and hormonal perturbations have increased the life span of several mammalian species without necessarily addressing features of age-related metabolic decline. These interventions include inhibition of the mammalian target of rapamycin and lifetime deficiency in GH/IGF-1 signaling. However, strategies to treat aging in humans, such as hormone replacement, have mostly failed to achieve their desired response. We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries. Although life span has been the major outcome of interest in the laboratory, a special focus is made in this study on healthspan, as improved quality of life is the goal when translated to humans.

Original languageEnglish (US)
Pages (from-to)1315-1322
Number of pages8
JournalDiabetes
Volume61
Issue number6
DOIs
StatePublished - Jun 2012

Fingerprint

Metabolic Networks and Pathways
Somatomedins
Growth Hormone
Caloric Restriction
Intra-Abdominal Fat
Sirolimus
Body Composition
Insulin Resistance
Rodentia
Steroids
Maintenance
Quality of Life
Hormones
Insulin

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

The critical role of metabolic pathways in aging. / Barzilai, Nir; Huffman, Derek M.; Muzumdar, Radhika H.; Bartke, Andrzej.

In: Diabetes, Vol. 61, No. 6, 06.2012, p. 1315-1322.

Research output: Contribution to journalArticle

Barzilai, Nir ; Huffman, Derek M. ; Muzumdar, Radhika H. ; Bartke, Andrzej. / The critical role of metabolic pathways in aging. In: Diabetes. 2012 ; Vol. 61, No. 6. pp. 1315-1322.
@article{424f059730b44a84b337a9f351b825e3,
title = "The critical role of metabolic pathways in aging",
abstract = "Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death. The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids. Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents. Meanwhile, pharmacologic interventions and hormonal perturbations have increased the life span of several mammalian species without necessarily addressing features of age-related metabolic decline. These interventions include inhibition of the mammalian target of rapamycin and lifetime deficiency in GH/IGF-1 signaling. However, strategies to treat aging in humans, such as hormone replacement, have mostly failed to achieve their desired response. We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries. Although life span has been the major outcome of interest in the laboratory, a special focus is made in this study on healthspan, as improved quality of life is the goal when translated to humans.",
author = "Nir Barzilai and Huffman, {Derek M.} and Muzumdar, {Radhika H.} and Andrzej Bartke",
year = "2012",
month = "6",
doi = "10.2337/db11-1300",
language = "English (US)",
volume = "61",
pages = "1315--1322",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "6",

}

TY - JOUR

T1 - The critical role of metabolic pathways in aging

AU - Barzilai, Nir

AU - Huffman, Derek M.

AU - Muzumdar, Radhika H.

AU - Bartke, Andrzej

PY - 2012/6

Y1 - 2012/6

N2 - Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death. The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids. Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents. Meanwhile, pharmacologic interventions and hormonal perturbations have increased the life span of several mammalian species without necessarily addressing features of age-related metabolic decline. These interventions include inhibition of the mammalian target of rapamycin and lifetime deficiency in GH/IGF-1 signaling. However, strategies to treat aging in humans, such as hormone replacement, have mostly failed to achieve their desired response. We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries. Although life span has been the major outcome of interest in the laboratory, a special focus is made in this study on healthspan, as improved quality of life is the goal when translated to humans.

AB - Aging is characterized by a deterioration in the maintenance of homeostatic processes over time, leading to functional decline and increased risk for disease and death. The aging process is characterized metabolically by insulin resistance, changes in body composition, and physiological declines in growth hormone (GH), insulin-like growth factor-1 (IGF-1), and sex steroids. Some interventions designed to address features of aging, such as caloric restriction or visceral fat depletion, have succeeded in improving insulin action and life span in rodents. Meanwhile, pharmacologic interventions and hormonal perturbations have increased the life span of several mammalian species without necessarily addressing features of age-related metabolic decline. These interventions include inhibition of the mammalian target of rapamycin and lifetime deficiency in GH/IGF-1 signaling. However, strategies to treat aging in humans, such as hormone replacement, have mostly failed to achieve their desired response. We will briefly discuss recent advances in our understanding of the complex role of metabolic pathways in the aging process and highlight important paradoxes that have emerged from these discoveries. Although life span has been the major outcome of interest in the laboratory, a special focus is made in this study on healthspan, as improved quality of life is the goal when translated to humans.

UR - http://www.scopus.com/inward/record.url?scp=84861885929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861885929&partnerID=8YFLogxK

U2 - 10.2337/db11-1300

DO - 10.2337/db11-1300

M3 - Article

C2 - 22618766

AN - SCOPUS:84861885929

VL - 61

SP - 1315

EP - 1322

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 6

ER -